Jie Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jie Wu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Lulan Li
Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2 shared publicationsFeng Wu
Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
1 shared publication- Haihong Fang
Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China
1 shared publication - Hong Yang
Department of Critical Care Medicine, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
1 shared publication Hongbin Hu
Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
1 shared publicationJiancheng Wang
Department of Intensive Care Unit, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, Peoples Republic of China
1 shared publication
Latest Publications
- 19 October 2022
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 83, 110960
Association between dexmedetomidine administration and outcomes in critically ill patients with sepsis-associated acute kidney injury
- 19 October 2022
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 83, 110960
Association between dexmedetomidine administration and outcomes in critically ill patients with sepsis-associated acute kidney injury
- 1 December 2021
- Published by Elsevier in International Immunopharmacology
- Vol. 101 (Pt B) , 108331
Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages
- 1 December 2021
- Published by Elsevier in International Immunopharmacology
- Vol. 101 (Pt B) , 108331
Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages